Zobrazeno 1 - 10
of 44
pro vyhledávání: '"F. G. Jiménez-Núñez"'
Autor:
Natalia Mena-Vázquez, M. Rojas-Giménez, Antonio Fernández-Nebro, F. G. Jiménez-Núñez, Sara Manrique-Arija, C.M. Romero-Barco, Gisela Diaz-Cordovés, Inmaculada Ureña-Garnica
Publikováno v:
Reumatología Clínica (English Edition). 17:588-594
Objective To assess the effectiveness, safety and cost of Etanercept biosimilar in patients with rheumatoid arthritis (RA), spondyloarthritis (SpA) and psoriatic arthritis (PsA) compared to the standard drug in real clinical practice. Patients and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6884da93f2943371e5b26891c67bdbfa
https://doi.org/10.1016/j.reumae.2020.06.010
https://doi.org/10.1016/j.reumae.2020.06.010
Autor:
F. G. Jiménez-Núñez, C.M. Romero-Barco, M. Rojas-Giménez, Inmaculada Ureña-Garnica, Antonio Fernández-Nebro, Natalia Mena-Vázquez, Sara Manrique-Arija, Gisela Diaz-Cordovés
Publikováno v:
Reumatología Clínica. 17:588-594
Objective To assess the effectiveness, safety and cost of Etanercept biosimilar in patients with rheumatoid arthritis (RA), spondyloarthritis (SpA) and psoriatic arthritis (PsA) compared to the standard drug in real clinical practice. Patients and me
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8e184f56c9a66db3fcfeea5c03866a30
https://doi.org/10.1016/j.reuma.2020.06.008
https://doi.org/10.1016/j.reuma.2020.06.008
Autor:
María Carmen Aguilar-Hurtado, Francisco Javier Godoy-Navarrete, Sara Manrique-Arija, Natalia Mena-Vázquez, F Espildora, F. G. Jiménez-Núñez, Antonio Fernández-Nebro, Inmaculada Ureña-Garnica, María Isabel Padin-Martín, C.M. Romero-Barco
Publikováno v:
Clinical Rheumatology. 40:2377-2385
To analyze the diagnostic utility of lung ultrasound (US) to detect interstitial lung disease (ILD) in rheumatoid arthritis (RA) patients comparing with high-resolution computed tomography (HRCT) PATIENTS AND METHODS: We performed a cross-sectional,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba2b012cc31fce84f1f39c6d37e63658
https://doi.org/10.1007/s10067-021-05655-1
https://doi.org/10.1007/s10067-021-05655-1
Frequency of Polyautoimmunity in Patients With Rheumatoid Arthritis and Systemic Lupus Erythematosus
Autor:
Sara Manrique-Arija, Natalia Mena-Vázquez, Inmaculada Ureña-Garnica, F. G. Jiménez-Núñez, M.C. Ordoñez-Cañizares, Antonio Fernández-Nebro, Rocio Redondo-Rodriguez
Publikováno v:
JCR: Journal of Clinical Rheumatology. 28:e38-e43
Objective To describe the frequency of polyautoimmunity and multiple autoimmune syndrome in patients with rheumatoid arthritis (RA) and patients with systemic lupus erythematosus (SLE). Patients and methods This was a cross-sectional observational st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a26d3d2a3582c3246f26867ec8b7adb9
https://doi.org/10.1097/rhu.0000000000001574
https://doi.org/10.1097/rhu.0000000000001574
Autor:
Carmen Gomez-Cano, Natalia Mena-Vázquez, Lorena Pérez-Albaladejo, María Isabel Padin-Martín, María Carmen Aguilar-Hurtado, C.M. Romero-Barco, Francisco Javier Godoy-Navarrete, Antonio Fernández-Nebro, F. G. Jiménez-Núñez, Inmaculada Ureña-Garnica, F Espildora, Isabel Añón-Oñate, Sara Manrique-Arija
Publikováno v:
Clinical Rheumatology. 40:133-142
To analyze the effect of disease-modifying antirheumatic drugs (DMARDs) on the outcome of interstitial lung disease secondary to rheumatoid arthritis (RA-ILD).We performed a multicenter, prospective, observational study of patients with RA-ILD receiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ae51e5730ec99f92b4acca7af73eb69
https://doi.org/10.1007/s10067-020-05227-9
https://doi.org/10.1007/s10067-020-05227-9
Autor:
Inmaculada Ureña-Garnica, Antonio Fernández-Nebro, Natalia Mena-Vázquez, M. Rojas-Giménez, Sara Manrique-Arija, F. G. Jiménez-Núñez
Publikováno v:
Reumatología Clínica. 15:21-26
Resumen Objetivo Evaluar la efectividad y la seguridad de tocilizumab (TCZ) en pacientes con artritis reumatoide (AR) en practica clinica; la optimizacion de dosis y el cambio de formulacion intravenosa (iv) a subcutanea (sc). Material y metodos Estu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8dde3929f3f04d8f424ea9e4df9a9b23
https://doi.org/10.1016/j.reuma.2017.05.012
https://doi.org/10.1016/j.reuma.2017.05.012
Autor:
M. Rojas-Giménez, Natalia Mena-Vázquez, Antonio Fernández-Nebro, Sara Manrique-Arija, Inmaculada Ureña-Garnica, F. G. Jiménez-Núñez
Publikováno v:
Reumatología Clínica (English Edition). 15:21-26
Objective To evaluate the effectiveness and safety of tocilizumab (TCZ) in patients with rheumatoid arthritis (RA) in clinical practice, establishing the optimised regimen and switching from intravenous (IV) to subcutaneous (SC) therapy. Material and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e64e71830311f9fecbba79317704e39
https://doi.org/10.1016/j.reumae.2017.05.007
https://doi.org/10.1016/j.reumae.2017.05.007
Autor:
Natalia Mena-Vázquez, I. Ureña, F. G. Jiménez-Núñez, Begoña Oliver-Martos, José Rioja, Antonio Fernández-Nebro, Pedro Valdivielso, Salomé Abad-Sánchez, Leovigildo Ginel-Mendoza, Sara Manrique-Arija
Publikováno v:
BMJ Open
BMJ Open, Vol 11, Iss 2 (2021)
BMJ Open, Vol 11, Iss 2 (2021)
ObjectivesTo describe the prevalence of insulin resistance (IR) in patients with established rheumatoid arthritis (RA) and to analyse the contribution of cumulative inflammatory burden and other factors to its development.DesignObservational cross-se
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97c5acd31e54ad0c03a94ff2d448193a
https://bmjopen.bmj.com/content/bmjopen/11/2/e044749.full.pdf
https://bmjopen.bmj.com/content/bmjopen/11/2/e044749.full.pdf
Autor:
Francisco Javier Godoy-Navarrete, Natalia Mena-Vázquez, Antonio Fernández-Nebro, María Isabel Padin-Martín, F. G. Jiménez-Núñez, C.M. Romero-Barco, F Espildora, María Carmen Aguilar-Hurtado, Sara Manrique-Arija, Inmaculada Ureña-Garnica
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ed93b3e4b4de983892ea732a2e6e0b1
https://hdl.handle.net/10668/17598
https://hdl.handle.net/10668/17598
Autor:
L. Perez-Albaladejo, Inmaculada Ureña-Garnica, Añón-Oñate I, C.M. Romero-Barco, María Carmen Aguilar-Hurtado, Vázquez Nm, F. G. Jiménez-Núñez, Sara Manrique-Arija, Antonio Fernández-Nebro, Francisco Javier Godoy-Navarrete, C. Gomez-Cano, Padin-Martín Mi
Objectives To analyze the effect of disease-modifying antirheumatic drugs (DMARDs) on the outcome of interstitial lung disease secondary to rheumatoid arthritis (RA-ILD). Patients and methods We performed a multicenter, prospective, observational stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f1f27bc8483089378d2640cabd3cd84e
https://doi.org/10.21203/rs.3.rs-18463/v1
https://doi.org/10.21203/rs.3.rs-18463/v1